https://newsletter.glp1studio.com/p/failed-bariatric-surgery-patientsGLP-1 Studioen2026-09-21T12:10:09+00:00Failed bariatric surgery patients get a new drug option to tryhttps://newsletter.glp1studio.com/p/novo-says-ozempic-supply-holds-steadyGLP-1 Studioen2026-09-21T12:10:06+00:00Novo says Ozempic supply holds steady across Canadahttps://newsletter.glp1studio.com/p/four-new-lawsuits-against-novo-andGLP-1 Studioen2026-09-20T12:10:11+00:00GLP-1 trials now reach cancer patients, sleep apnea and liver diseasehttps://newsletter.glp1studio.com/p/smaller-carts-smaller-portions-foodGLP-1 Studioen2026-09-20T12:10:09+00:00Smaller carts, smaller portions: food industry counts the cost